Research2 sources
GLP-1 Pill Shows Benefit in Sleep Apnea
The Brief · written from 2 sources
- In a trial, adults with moderate-to-severe sleep apnea and excess weight had significantly fewer breathing-interruption episodes during sleep after one year of a daily oral GLP-1 medication, orforglipron.
- The comparison group was adults taking a placebo, according to the reported results.
Why it matters
The results suggest an oral GLP-1 drug may reduce sleep apnea episodes in people with excess weight, which could matter for future treatment options; readers should weigh these findings as those of a single reported study.
Who’s affected
- clinicians treating sleep apnea and obesity
- adults with excess weight and moderate-to-severe sleep apnea
- #sleep apnea
- #glp-1
- #obesity
- #clinical trial
- #orforglipron
(MedPage Today) -- The oral GLP-1 receptor agonist orforglipron (Foundayo) improved sleep-disordered breathing in patients with moderate-to-severe obstructive sleep apnea and overweight or obesity, two phase III trials showed. For the treatment...
Timeline
Full coverage · 2 sources
- 3h ago ↗
MedPageToday.com - medical news for physicians
GLP-1 Pill Shows Benefit in Sleep Apnea
- 5h ago ↗
Medical Xpress - latest medical and health news stories
Daily, oral GLP-1 medication reduced episodes of sleep apnea in adults with excess weight